The news surrounding this technology has only just begun and it is all being backed with positive 'field" data.
As this unfolds supported by an FDA approval along with global revenue streams occurring - now would not be the time to now be selling on any news.
Also, institutions won't let this opportunity pass them by - when that occurs the current share price will take a serious jolt north.
Ann: Positive Interim Results From Clinical Trial at St Vincent's, page-15
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.015(6.82%) |
Mkt cap ! $138.3M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 24.0¢ | 22.0¢ | $220.3K | 969.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 393626 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 141247 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |